Skip to main content
. Author manuscript; available in PMC: 2023 Apr 28.
Published in final edited form as: Am J Nephrol. 2022 Apr 28;53(6):435–445. doi: 10.1159/000524166

Table 4.

Odds Ratios for Moderate/Severe Cognitive Impairment in CKD Adjusted for eGFR and UACR

Risk Factors included in Models Unadjusted Models All CKD N = 418–436 Adjusted Model All CKD (eGFR < 60) N = 411
OR (95% CIa) p-value OR (95% CIa) p-value FDRb adjusted p-value
Age (10-year increase) 1.11 (0.90, 1.36) 0.33 1.32 (1.00, 1.74) 0.05 0.31
Gender: Male vs Female 1.34 (0.89, 2.02) 0.16 1.48 (0.89, 2.47) 0.13 0.46
Years of Education (1-year increase) 0.93 (0.86, 1.003) 0.06 0.98 (0.90, 1.07) 0.63 0.95
Black Race 3.32 (1.97, 5.59) < 0.001 3.14 (1.50, 6.55) 0.002 0.04
Diabetes c 1.15 (0.77, 1.74) 0.50 0.91 (0.55, 1.52) 0.72 0.99
Stroke / TIA d 2.10 (1.28, 3.45) 0.003 1.70 (0.95, 3.04) 0.08 0.36
Smoker e 1.73 (0.92, 3.23) 0.09 1.10 (0.50, 2.40) 0.82 1.00
CVD f 1.67 (1.10, 2.54) 0.02 1.27 (0.78, 2.06) 0.34 0.81
Pulse Pressure (SBP minus DBP) 1.01 (1.00, 1.02) 0.08 1.01 (0.99, 1.02) 0.36 0.83
Low Hemoglobin g 1.29 (0.85, 1.94) 0.227 0.87 (0.51, 1.47) 0.60 0.95
Phosphorous (1 mg/dL increase) 1.39 (1.04, 1.87) 0.03 1.32 (0.91, 1.90) 0.14 0.46
Calcium (1 mg/dL increase) 0.72 (0.50, 1.03) 0.07 1.03 (0.65, 1.63) 0.90 1.00
PTH (100 pg/mL increase) 1.03 (0.94, 1.14) 0.53 1.04 (0.93, 1.16) 0.49 0.85
Low Bicarbonate (CO2 <20 mEq/L) 2.05 (0.89, 4.71) 0.09 1.63 (0.62, 4.27) 0.32 0.80
Cholesterol (10 mg/dL decrease) 1.02 (0.97, 1.07) 0.49 0.99 (0.93, 1.05) 0.66 0.95
TNF αR1 (1000 pg/mL increase) 1.27 (1.05, 1.53) 0.01 1.40 (1.02, 1.93) 0.04 0.26
a

CI refers to Confidence Interval;

b

False Discovery Rate;

c

Diabetes defined as Glucose ≥200 or A1c% ≥6.5 or DM meds or self-report;

d

Stroke or TIA (history of) from QVSFS;

e

Smoker: any cigarettes in past month;

f

Cardiovascular disease (CVD): history of MI, angina, CHF or peripheral vascular disease;

g

WHO definition for low hemoglobin: <13 g/dL for men, <12 g/dL for women